This Insider Has Just Sold Shares In Tenet Healthcare
Some Tenet Healthcare Corporation (NYSE:THC) shareholders may be a little concerned to see that the Chairman & CEO, Saumya Sutaria, recently sold a substantial US$28m worth of stock at a price of US$276 per share. That's a big disposal, and it decreased their holding size by 19%, which is notable but not too bad.
The Last 12 Months Of Insider Transactions At Tenet Healthcare
In fact, the recent sale by Saumya Sutaria was the biggest sale of Tenet Healthcare shares made by an insider individual in the last twelve months, according to our records. So we know that an insider sold shares at around the present share price of US$268. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.
Insiders in Tenet Healthcare didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
See our latest analysis for Tenet Healthcare
I will like Tenet Healthcare better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
Insider Ownership
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Tenet Healthcare insiders own about US$209m worth of shares (which is 0.9% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
What Might The Insider Transactions At Tenet Healthcare Tell Us?
Insiders sold Tenet Healthcare shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. But it is good to see that Tenet Healthcare is growing earnings. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Tenet Healthcare. Our analysis shows 3 warning signs for Tenet Healthcare (1 is significant!) and we strongly recommend you look at them before investing.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.